Putnam Global Health Care Fund Class C (PCHSX)

Fund Assets	1.49B
Expense Ratio	1.795%
Min. Investment	$500
Turnover	67.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 22, 2025

Previous Close	36.14
YTD Return	6.23%
1-Year Return	14.81%
5-Year Return	32.76%
52-Week Low	32.58
52-Week High	38.01
Beta (5Y)	0.64
Holdings	44
Inception Date	Jul 26, 1999

About PCHSX

Putnam Global Health Care Fund Class C is a mutual fund primarily focused on capital appreciation through investments in the global health care industry. Established in 1999, this fund allocates at least 80% of its assets to securities of companies operating within various sectors of health care, including biotechnology, pharmaceuticals, medical devices, and health service providers. It predominantly invests in common stocks of large and midsize companies worldwide that are considered to have favorable growth or value potential based on deep fundamental research and ongoing monitoring of scientific innovation and regulatory changes. The fund combines technical expertise with active management to capture opportunities in the health care sector. With a diverse portfolio of approximately 81 holdings, the fund plays a significant role in offering exposure to the dynamic and evolving health care market, catering to investors seeking targeted industry growth within the broader equity space.

• Fund Family: Franklin Templeton, Inc
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: PCHSX
• Share Class: Class C Shares
• Index: MSCI World/Health Care NR

Performance

PCHSX had a total return of 14.81% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.30%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
PHSYX	Class Y Shares	0.79%
PHSTX	Class A Shares	1.04%
PHSRX	Class R Shares	1.29%

Top 10 Holdings

59.83% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.63%
Johnson & Johnson	JNJ	9.44%
AbbVie Inc.	ABBV	6.74%
UnitedHealth Group Incorporated	UNH	6.03%
Merck & Co., Inc.	MRK	5.75%
Novartis AG	NOVN	4.91%
Thermo Fisher Scientific Inc.	TMO	4.05%
AstraZeneca PLC	AZN	3.84%
Intuitive Surgical, Inc.	ISRG	3.39%
Vertex Pharmaceuticals Incorporated	VRTX	3.06%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$0.9834	Dec 22, 2025
Dec 23, 2024	$2.533	Dec 26, 2024
Dec 21, 2023	$3.145	Dec 26, 2023
Dec 22, 2022	$4.379	Dec 27, 2022
Dec 22, 2021	$7.326	Dec 27, 2021
Dec 23, 2020	$5.447	Dec 28, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error